v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows provided by (used in) operating activities    
Net income (loss) $ 1,494,168 $ 1,138,429
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities    
Amortization, accretion and depreciation (47,573) 9,156
Equity in undistributed (earnings) losses of other ventures (5,503) (8,601)
Net realized and unrealized (gains) losses on investments 300,285 (365,719)
Change in:    
Premiums receivable (1,016,961) (1,815,384)
Prepaid reinsurance premiums (573,964) (527,315)
Reinsurance recoverable 36,427 180,417
Deferred acquisition costs and value of business acquired (167,589) (179,919)
Reserve for claims and claim expenses (33,211) 1,610,272
Unearned premiums 1,147,863 1,610,740
Reinsurance balances payable 515,495 243,620
Other (109,513) (268,362)
Net cash provided by (used in) operating activities 1,539,924 1,627,334
Cash flows provided by (used in) investing activities    
Proceeds from sales and maturities of fixed maturity investments trading 9,506,883 7,036,234
Purchases of fixed maturity investments trading (9,988,155) (6,198,055)
Proceeds from sales of short term investments 25,333,612 17,018,711
Purchases of short term investments (24,482,022) (18,387,556)
Proceeds from sales of equity investments 472,453 601
Purchases of equity investments (647,381) (766,571)
Proceeds from sales of other investments 691,558 619,059
Purchases of other investments (1,112,900) (859,651)
Purchases of investments in other ventures (24,844) (565)
Return of investments in other ventures 2,432 203
Net settlements of derivatives 37,135 287,036
Net cash provided by (used in) investing activities (211,229) (1,250,554)
Cash flows provided by (used in) financing activities    
Dividends paid – common shares (34,500) (38,720)
Dividends paid – preference shares (17,688) (17,688)
RenaissanceRe common share repurchases (702,466) (731,358)
Repayment of debt 0 (450,000)
Issuance of debt, net of expenses 0 789,992
Repayment of Medici Revolving Credit Facility 0 (40,000)
Drawdown of Medici Revolving Credit Facility 0 75,000
Subscriptions of third-party redeemable noncontrolling interest shares 4,500 103,825
Redemptions of third-party redeemable noncontrolling interest shares (965,454) (296,645)
Taxes paid on withholding shares (27,194) (21,533)
Net cash provided by (used in) financing activities (1,742,802) (627,127)
Effect of exchange rate changes on foreign currency cash (14,914) 2,424
Net increase (decrease) in cash and cash equivalents (429,021) (247,923)
Cash and cash equivalents, beginning of period 1,731,181 1,676,604
Cash and cash equivalents, end of period $ 1,302,160 $ 1,428,681